Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary

This publication has 9 references indexed in Scilit:

• The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy
  European Journal of Cancer and Clinical Oncology, 1987
• Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986
• The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985
• Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma
  Gynecologic Oncology, 1985
• The use of vimentin antibodies in the diagnosis of malignant mesothelioma
  Virchows Archiv, 1985
• Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
  British Journal of Cancer, 1984
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125
  International Journal of Gynecological Pathology, 1983
• Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell Types
  American Journal of Clinical Pathology, 1983